RECRUITING

Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is an observational, prospective cohort study that will recruit a diverse sample of 84 participants with newly diagnosed with unresectable, advanced hepatocellular carcinoma (HCC) at the UT Health Cancer Center in San Antonio. This study uses geriatric assessment tools with participants 65 years and older and collects adverse events and exploratory markers of aging for all participants.

Official Title

Characterizing Disease Biology, Treatment Patterns and Toxicity in Older Adults With Advanced Hepatocellular Carcinoma

Quick Facts

Study Start:2019-09-13
Study Completion:2026-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03894917

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Histologically or radiographically (CT or MRI) confirmed newly diagnosed hepatocellular carcinoma.
  2. * Age 18 years and older.
  3. * Patients with advanced, unresectable HCC as determined by the treating physician.
  1. * Patients with resectable HCC who are still candidates for locoregional therapy
  2. * Patients receiving prior systemic or locoregional therapy

Contacts and Locations

Study Contact

Maggie Tomasini, MPH
CONTACT
210-450-0507
tomasinim@uthscsa.edu

Principal Investigator

Sukeshi Patel Arora, MD
PRINCIPAL_INVESTIGATOR
Mays Cancer Center

Study Locations (Sites)

Mays Cancer Center
San Antonio, Texas, 78229
United States

Collaborators and Investigators

Sponsor: The University of Texas Health Science Center at San Antonio

  • Sukeshi Patel Arora, MD, PRINCIPAL_INVESTIGATOR, Mays Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2019-09-13
Study Completion Date2026-12

Study Record Updates

Study Start Date2019-09-13
Study Completion Date2026-12

Terms related to this study

Additional Relevant MeSH Terms

  • Carcinoma, Hepatocellular